2020 | | Neurogenin-1 Overexpression Increases the Therapeutic Effects of Mesenchymal Stem Cells through Enhanced Engraftment in an Ischemic Rat Brain | 김성수, 서해영, 윤정선, 홍지만 |
2022 | | Novel Gene Signatures as Prognostic Biomarkers for Predicting the Recurrence of Hepatocellular Carcinoma | 김순선, 은정우, 정재연, 조효정 |
2021 | | Outcomes and loop pattern analysis of a road-map technique for ercp with side-viewing duodenoscope in patients with billroth ii gastrectomy (With video) | 김순선, 김진홍, 양민재, 유병무, 임선교, 황재철 |
2021 | | Overexpressed proteins in hcc cell-derived exosomes, CCT8, and cofilin-1 are potential biomarkers for patients with HCC | 김순선, 은정우, 정재연, 조효정 |
2020 | | Pathway-Based Integrative Analysis of Metabolome and Microbiome Data from Hepatocellular Carcinoma and Liver Cirrhosis Patients | 김순선, 정재연 |
2020 | | Predictive score for hepatocellular carcinoma after hepatitis B e antigen loss in patients treated with entecavir or tenofovir | 김순선, 정재연 |
2023 | | Recurrence of hepatocellular carcinoma in noncirrhotic patients with nonalcoholic fatty liver disease versus hepatitis B infection | 김순선 |
2024 | | Regular Alpha-Fetoprotein Tests Boost Curative Treatment and Survival for Hepatocellular Carcinoma Patients in an Endemic Area | 김순선 |
2022 | | Relationship between the dynamics of non-alcoholic fatty liver disease and incident diabetes mellitus | 김순선, 박범희, 정재연, 조효정, 한지은 |
2023 | | Risk of Hepatitis C Virus Transmission through Acupuncture: A Systematic Review and Meta-Analysis | 김순선 |
2022 | | Risk Prediction Model Based on Magnetic Resonance Elastography-Assessed Liver Stiffness for Predicting Posthepatectomy Liver Failure in Patients with Hepatocellular Carcinoma | 김봉완, 김순선, 김재근, 은정우, 이제희, 정재연, 조효정, 허지미 |
2019 | | SAT-062-Edema index measured by bioelectrical impedance analysis predicts ascites or acute kidney injury after liver resection for hepatocellular carcinoma | 김봉완, 김순선, 왕희정, 은정우, 이길호, 정재연, 조효정 |
2022 | | Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations | 김순선, 정재연 |
2020 | | Serum Exosomal MicroRNA, miR-10b-5p, as a Potential Diagnostic Biomarker for Early-Stage Hepatocellular Carcinoma | 김순선, 은정우, 정재연, 조효정 |
2020 | | Serum small extracellular vesicle-derived LINC00853 as a novel diagnostic marker for early hepatocellular carcinoma | 김순선, 은정우, 정재연, 조효정 |
2024 | | SGLT2i impact on HCC incidence in patients with fatty liver disease and diabetes: a nation-wide cohort study in South Korea | 김순선, 정재연, 조효정 |
2019 | | Staged partial hepatectomy versus transarterial chemoembolization for the treatment of spontaneous hepatocellular carcinoma rupture: a multicenter analysis in Korea | 김순선 |
2023 | | Tenofovir disoproxil fumarate versus tenofovir alafenamide on risk of osteoporotic fracture in patients with chronic hepatitis B: A nationwide claims study in South Korea | 김순선 |
2020 | | The alphaC helix of TIRAP holds therapeutic potential in TLR-mediated autoimmune diseases | 김순선, 서창희, 정재연 |
2024 | | The Impact of Statins on the Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib or Lenvatinib | 김순선, 노충균, 박범희, 양민재, 은정우, 이길호, 임선교, 정재연, 조효정, 한지은 |
2020 | | Treatment and prognosis of hepatic epithelioid hemangioendothelioma based on SEER data analysis from 1973 to 2014 | 김순선, 노오규, 양민재, 임선교, 정재연, 조효정, 황재철 |
2023 | | Tumor Endothelial Cells-Associated Integrin Alpha-6 as a Promising Biomarker for Early Detection and Prognosis of Hepatocellular Carcinoma | 김순선, 은정우, 정재연, 조효정, 한지은 |
2021 | | Update on liver disease management during the pandemic of coronavirus disease 2019 (Covid-19): 2021 kasl guideline | 김순선 |